| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| ILR-H82F3 | Human | Biotinylated Human IL-23 R Protein, Fc,Avitag™ |  |
|
|
| ILR-H5254 | Human | Human IL-23 R Protein, Fc Tag |  |
|
|
| ILR-H52H4 | Human | Human IL-23 R Protein, His Tag (SPR verified) |  |
|
|
| ILR-M5251 | Mouse | Mouse IL-23 R Protein, Fc Tag |  |
|
Captured Human IL-23 R, Fc Tag (Cat. No. ILR-H5254) on CM5 chip via anti-human IgG Fc antibodies surface can bind Human IL23A & IL12B, His Tag (Cat. No. ILB-H52W5) with an affinity constant of 5.36 nM as determined in a SPR assay (Biacore T200) (Routinely tested).
Biotinylated Human IL-23A&IL-12B Heterodimer Protein, His,Avitag&Tag Free (Cat. No. ILB-H82W6) captured on Biotin CAP - Series S sensor Chip can bind Human IL-23 R, His Tag (SPR verified) (Cat. No. ILR-H52H4) affinity constant of 3.39 nM as determined in a SPR assay (Biacore 8K) (QC tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Tildrakizumab-asmn | SUNPG 1623-II; SUNPG-1623; SUNPG-1622-I; SUNPG-1623-I; MK-3222; SCH-900222; SUNPG-1622; SUNPG-1623-III; SUNPG-1623-IV | Approved | Merck Sharp & Dohme Corp | Ilumetri, Ilumya | Japan | Plaque psoriasis | s:9:"Sun Pharm"; | 2018-03-20 | Spondylitis, Ankylosing; Psoriasis; Arthritis, Psoriatic; Plaque psoriasis | Details |
This web search service is supported by Google Inc.
A-Z